Navis Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Navis Wealth Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$711K	Buy	4,209 +3	+0.1%	+$513	0.36%	75
2025 Q4	$710K	Buy	4,206 +5	+0.1%	+$812	0.3%	79
2025 Q3	$607K	Buy	4,201 +2	+0%	+$273	0.45%	47
2025 Q2	$531K	Hold	4,199	–	–	0.45%	50
2025 Q1	$537K	Buy	4,199 +4	+0.1%	+$542	0.53%	43
2024 Q4	$555K	Buy	4,195 +2	+0%	+$281	0.61%	40
2024 Q3	$611K	Buy	4,193 +6	+0.1%	+$868	0.66%	38
2024 Q2	$575K	Sell	4,187 -181	-4%	-$24.2K	0.66%	37
2024 Q1	$599K	Buy	4,368 +4	+0.1%	+$546	0.72%	33
2023 Q4	$593K	Buy	4,364 +10	+0.2%	+$1.22K	0.77%	32
2023 Q3	$532K	Hold	4,354	–	–	0.77%	31
2023 Q2	$553K	Hold	4,354	–	–	0.51%	31
2023 Q1	$562K	Buy	4,354 +2	+0%	+$262	0.62%	29
2022 Q4	$571K	Buy	+4,352	New	+$562K	0.81%	27

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Navis Wealth Advisors's IBB Position: Q1 2026 in Review

Navis Wealth Advisors increased its iShares Biotechnology ETF (IBB) stake by 0.07% in Q1 2026, buying an estimated $513 and bringing the position to 4,209 shares worth $711K. The position accounts for 0.36% of the portfolio, ranked #75.

Navis Wealth Advisors first reported a position in IBB in Q4 2022 and has held it in 14 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Navis Wealth Advisors held 4,209 shares of iShares Biotechnology ETF worth $711K as of Q1 2026.
Navis Wealth Advisors bought 3 iShares Biotechnology ETF shares in Q1 2026, an estimated $513.
iShares Biotechnology ETF made up 0.36% of Navis Wealth Advisors's portfolio in Q1 2026, its #75 holding.
Navis Wealth Advisors first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 14 quarters since.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Navis Wealth Advisors's 13F filing for Q1 2026, filed 15 May 2026.